CORC  > 四川大学
La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease
Meng, Huimin; Sun, Xue; Song, Yanhui; Zou, Jianxuan; An, Gangli; Jin, Zeming; Yang, Lin
刊名CLINICAL IMMUNOLOGY
2018
卷号Vol.192页码:40-49
关键词Autoantibodies La/SSB Chimeric autoantibody receptor Autoimmune diseases NK92MI cells
ISSN号1521-6616
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1833357
专题四川大学
作者单位1.USA
2.Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Sichuan, Peoples R China
3.Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China
4.Soochow Univ, Dept Emergency, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China
5.PersonGen BioTherapeut Suzhou Co Ltd, Suzhou, Peoples R China
6.Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou, Jiangsu, Peoples R China
7.Soochow Univ, State Key Lab Radiat Med & Protect, Suzhou, Jiangsu, Peoples R China
8.Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX
推荐引用方式
GB/T 7714
Meng, Huimin,Sun, Xue,Song, Yanhui,et al. La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease[J]. CLINICAL IMMUNOLOGY,2018,Vol.192:40-49.
APA Meng, Huimin.,Sun, Xue.,Song, Yanhui.,Zou, Jianxuan.,An, Gangli.,...&Yang, Lin.(2018).La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease.CLINICAL IMMUNOLOGY,Vol.192,40-49.
MLA Meng, Huimin,et al."La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease".CLINICAL IMMUNOLOGY Vol.192(2018):40-49.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace